Document is current
Any future updates will be listed below
-
Authors
,
Hoffman, Joshua
Fejerman, Laura
Hu, Donglei
Huntsman, Scott
Li, Min
John, Esther M.
Torres-Mejia, Gabriela
Kushi, Larry
Ding, Yuan Chun
Weitzel, Jeffrey
Neuhausen, Susan L.
Lott, Paul
Echeverry, Magdalena
Carvajal-Carmona, Luis
Burchard, Esteban
Eng, Celeste
Long, Jirong
Zheng, Wei
Olopade, Olufunmilayo
Huo, Dezheng
Haiman, Christopher
Ziv, Elad http://orcid.org/0000-0002-2324-2884
-
Funding
Funding for this research was provided by:
National Cancer Institute (K24CA169004, R01CA120120, R01CA184545, R25CA112355, CA63446, CA77305, UM1 CA164920, R01 CA63464, R37 CA54281, R01 CA132839, 5UM1CA164973, R01CA148667, UM1 CA182910, CA142996, CA161032)
U.S. Department of Defense (DAMD17-96-1-6071)
California Breast Cancer Research Program (7PB-0068)
Consejo Nacional de Ciencia y Tecnología (SALUD-2002-C01-7462)
GlaxoSmithKline foundation
V Foundation for Cancer Research
American Cancer Society (MRSG-13-063-01-TBG and CRP-10-119-01-CCE)
Susan G. Komen for the Cure
Breast Cancer Research Foundation
- License Information
-
More Information
Article History
Received: 9 April 2018
Accepted: 4 December 2018
First Online: 14 January 2019
Ethics approval and consent to participate
: The following Institutional Review Boards (IRBs) have approved the collection of different datasets, which have contributed to this study: University of California, San Francisco, the Cancer Prevention Institute of California, University of Southern California, Kaiser Permanente Division of Research Northern California, University of Chicago, Vanderbilt University, National Institute of Public Health, Mexico.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
